Company Announcements

Horizon Discovery exclusively licensed in August new X-MAN (gene X-Mutant And Normal) cell lines from the University of Minnesota.

Baseclick announced in August that it raised an additional €1.2 million ($1.7 million) from private investors and BASF Venture Capital in a second financing round.

In September, ABR-Affinity BioReagents, a Thermo Fisher Scientific company, agreed to distribute antibody products from Genesis Biotech and Good Biotech in the US, bringing its portfolio to more than 32,000 antibodies and research reagents.

In September, Olink Bioscience promoted Executive Vice President and Chief Scientific Officer Dr. Simon Fredriksson to president and CEO. Björn Ekström, retiring president and CEO, has joined the Board.

Techulon named BioConcept as a European distributor for its Glycofect polymeric nanoparticle–delivery transfection reagents.

American Peptide Company (APC), a provider of peptide and peptide conjugates, named Minoru Sakakibara president and CEO in September. He was previously part of the senior management of parent company Otsuka Chemical. Former CEO and President Takahiro Ogata was promoted to CEO of ILS, of which APC is a subsidiary.

In September, AMSBIO announced a pan-European partnership to market Chondrex’s arthritis and inflammation reagents.

2BScientific agreed to become the exclusive UK and Ireland distribution partner of IMGENEX.

In October, India’s Sisco Research Laboratories acquired fellow Indian firm Madras Biotech, which will be renamed the BioLit Division of Sisco.

Compass Biotechnologies expanded its relationship with PanGen Biotech, allowing it to offer PanGen’s lab reagent product lines for sale under the Compass name.

Product Introductions

Thermo Fisher Scientific launched in August Thermo Scientific Bioservative, a sample preservation matrix that does not require refrigeration. It ensures the cell viability of microbiological samples for up to seven days and delays the breakdown of RNA, DNA and peptides within a sample for up to 26 days.

Promega introduced the ONE-Glo + Tox Assay, which combines luciferase chemistry with a cell viability marker in a two-step, addition-only process to enable measurement of cell viability and gene expression in the single well of a plate.

In September, Biosearch Technologies released custom Stellaris FISH Probes for direct detection in single and multiplexed mRNA applications.

In September, MO BIO Laboratories introduced the RTS DNase Kit, which includes what it calls the first room-temperature stable DNase I enzyme.